Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

China to Crack Down on Drug Companies

  • Post author:Sam
  • Post published:May 28, 2018
  • Post category:Drug Industry Daily

Chinese regulators will crack down on corruption and unfair competition in the pharmaceutical sector, its government has announced. Source: Drug Industry Daily

Continue ReadingChina to Crack Down on Drug Companies

Cerno Pharmaceuticals Hit With Warning Letter Over Adulterated Products

  • Post author:Sam
  • Post published:May 28, 2018
  • Post category:Drug Industry Daily

The FDA slammed Cerno Pharmaceuticals for producing adulterated drugs at its Miami, Florida facility. Source: Drug Industry Daily

Continue ReadingCerno Pharmaceuticals Hit With Warning Letter Over Adulterated Products

Nonprofit Drugmakers Could Prompt Competitive Generic Pricing

  • Post author:Sam
  • Post published:May 28, 2018
  • Post category:Drug Industry Daily

The creation of nonprofit drugmakers could help remove the perverse incentives that keep generic drug prices high, three public health experts contend in a New England Journal of Medicine commentary.…

Continue ReadingNonprofit Drugmakers Could Prompt Competitive Generic Pricing

FTC Loses Challenge to Impax-Endo Opioid Agreement

  • Post author:Sam
  • Post published:May 28, 2018
  • Post category:Drug Industry Daily

An administrative law judge tossed out the Federal Trade Commission’s complaint challenging an agreement between Impax Laboratories and Endo Pharmaceuticals that the FTC claims illegally kept a generic version of…

Continue ReadingFTC Loses Challenge to Impax-Endo Opioid Agreement

U.S. Cancer Drug Spending Nearly Doubled From 2017: IQVIA

  • Post author:Sam
  • Post published:May 24, 2018
  • Post category:Drug Industry Daily

Spending on U.S. cancer medicines nearly doubled over the last five years—and may well double again in the next five years, a new report from IQVIA claims. Source: Drug Industry…

Continue ReadingU.S. Cancer Drug Spending Nearly Doubled From 2017: IQVIA

Administration Urges SCOTUS to Review Merck Case Over Failure-to-Warn Claims

  • Post author:Sam
  • Post published:May 24, 2018
  • Post category:Drug Industry Daily

The Trump administration is urging the Supreme Court to take up a case testing whether the FDA’s refusal to approve a warning label on drugs preempts state laws that may…

Continue ReadingAdministration Urges SCOTUS to Review Merck Case Over Failure-to-Warn Claims

Pfizer Agrees to Pay Nearly $24 Million to Put Kickback Claims to Rest

  • Post author:Sam
  • Post published:May 24, 2018
  • Post category:Drug Industry Daily

Pfizer agreed to pay $23.85 million and enter into a five-year corporate integrity agreement to settle U.S. government claims that the company engaged in illegal kickbacks to Medicare patients that…

Continue ReadingPfizer Agrees to Pay Nearly $24 Million to Put Kickback Claims to Rest

Seniors Paying More for Generics Through Medicare Part D, Study Finds

  • Post author:Sam
  • Post published:May 23, 2018
  • Post category:Drug Industry Daily

Seniors covered by Medicare Part D are paying more for generic drugs even though the market prices remain stable, according to new research by Avalere, a healthcare consulting firm. Source:…

Continue ReadingSeniors Paying More for Generics Through Medicare Part D, Study Finds

Drugs for Inhalation Anthrax Will be Considered Under Animal Rule

  • Post author:Sam
  • Post published:May 23, 2018
  • Post category:Drug Industry Daily

The FDA released guidelines for developing drugs for prophylaxis of inhalational anthrax, saying applications will be reviewed through the Animal Rule pathway due to safety and ethical concerns about human…

Continue ReadingDrugs for Inhalation Anthrax Will be Considered Under Animal Rule

FDA to Pull OTC Oral Benzocaine Products Unless They Drop Teething From Labels

  • Post author:Sam
  • Post published:May 23, 2018
  • Post category:Drug Industry Daily

In an alert that cited both safety and efficacy concerns, the FDA said it would pull over-the-counter oral benzocaine products from the market unless manufacturers discontinue their sale as teething…

Continue ReadingFDA to Pull OTC Oral Benzocaine Products Unless They Drop Teething From Labels
  • Go to the previous page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.